Viikinkaari 5 E (P.O. Box 56)
00014 University of Helsinki
Phone +358-(0)294 1911 (University)
Welcome to the Faculty of Pharmacy of the University of Helsinki!
Pharmacy is a multidisciplinary field of science. It specialises in medicinal treatment and studies drugs, medicines and their development, use and effects mainly from the point of view of natural sciences, health sciences, as well as social sciences.
The Faculty of Pharmacy offers Bachelor's, Master's and postgraduate programmes. The Faculty also provides professional postgraduate education in industrial pharmacy for those with a Bachelor or Master's degree in pharmacy and plays an active part in the continuing education in the field.
The Faculty is also nationally responsible for the Swedish-language Master's programmes in Pharmacy.
Microbial biofilm researchers gather in Viikki (27.1.2016)
The first national meeting in biofilm research will be held in Viikki campus, at the Faculty of Pharmacy on 29 January. Meeting will bring together the groups in Finland performing research in bacterial and fungal biofilms.
Consumption of Mentha plants may be good for the health (21.12.2015)
According to Karmen Kapp's doctoral dissertation, water extracts of peppermint teas were active against C. pneumoniae in vitro. Water extracts of Mentha plants showed in antibacterial activity against Staphylococcus aureus. Essential oils and mint flavouring hydrodistilled extracts inhibited the growth of Escherichia coli and S. aureus.
Prof. Risto Kostiainen and Prof. Arto Urtti awarded decorations by the President of the Republic (3.12.2015)
The President of the Republic, Sauli Niinistö, has decided to award Professor Risto Kostiainen and Professor Arto Urtti the decoration of the Knight, First Class,
of the Order of the White Rose of Finland on the Finnish Independence Day, 6 December.
Customer relations are essential for successful pharmaceutical product launch (1.11.2015)
A successful pharmaceutical product launch should focus on appropriate relationship marketing activities conducted in a timely manner to achieve customer acceptance and financial launch performance, says Minna Matikainen in her doctoral thesis.
Alfred Kordelin Prize for Professor Jari Yli-Kauhaluoma (6.11.2015)
Professor Jari Yli-Kauhaluoma has been awarded the Alfred Kordelin Prize for his work in drug development. The € 30,000 prize was handed out on 6 November in Helsinki.
More efficient derivatives of betulin for drug development (5.11.2015)
In her doctoral thesis, Raisa Haavikko has synthesized betulin derivatives aiming for example at medication against a protozoan parasite Leishmania donovani and aggressive prostate cancer.
The future of drug development: A stem cell-derived liver (29.9.2015)
PhD Yan-Ru Lou is developing a 3D liver derived from stem cells. Her work could speed up the drug discovery process considerably and eventually pave the way to personalised drugs.
Blending experiences: new tools in pharmacy teaching (21.9.2015)
Adyary Fallarero's course combines face-to-face and online lectures, audio feedback and online assignments.
Computer modelling helps creating drugs that reach even the retina (6.9.2015)
Eva María del Amo Páez developed new computer models for systemic and ocular pharmacokinetics and drug delivery. These models will hopefully speed up the development of new medications. It takes usually 12 to 15 years before a drug candidate reaches the market.
Three innovative projects get "risk-taking funding" from the Academy of Finland (6.9.2015)
The Academy of Finland has launched a funding trial to support particularly innovative and high-quality projects confirmed to involve promising risk-taking in terms of research. Out of the ten projects funded , three belong to the Faculty of Pharmacy. Leena Kontturi (Light triggered and pH sensitive liposomes with gold nanoparticles for posterior eye drug delivery), Yan-Ru Lou (Stem cell-derived, three-dimensional liver: the missing link in drug discovery) and Tapani Viitala (Real-time label-free cell based in vitro models for mechanistic understanding of emerging nanomedicines).
Oral medication for type 2 diabetes one step closer (31.8.2015)
A multifunctional nanocarrier holding anti-diabetic drugs slips right through the biological barriers along the gastrointestinal tract and delivers the medicine to the target.
Oluwaseun Oyemade to receive a Faculty for the Future grant (16.7.2015)
PhD student Oluwaseun Oyemade from Nigeria has been awarded a Faculty for the Future grant of the Schlumberger Foundation. The grant is intended for the 2015-2016 academic year to study under Professor Marja Airaksinen. More than a thousand applications were submitted and only 155 grants were awarded. Oluwaseun Oyemade's project concentrates on urban Nigerians and their coping with different health problems.
Nanocrystals: more tools for delivering poorly water soluble drugs (16.6.2015)
Nanocrystal technologies have been introduced as advantageous formulation approaches for poorly water soluble molecules. Annika Tuomela studied for her doctoral dissertation both liquid and solid nanocrystal dosage forms and prepared high-quality nanocrystal suspensions using wet milling technique. She also developed an in vivo effective nanocrystal suspension formulation for ocular delivery to treat elevated intraocular pressure.
Researchers discover weak spot in malaria-causing protozoan (15.6.2015)
The cell membrane of the protozoan that causes malaria has an enzyme that humans lack. Researchers are now designing a drug that would block the functioning of this enzyme in an effort to destroy the protozoan without impacting its human host.
Professor Arto Urtti nominated to the CRS advisory board (11.6.2015)
CRS (Controlled Release Society) is an international organisation covering the field of controlled release: scientific and technical efforts to regulate the spatial and temporal effects of agents in for example human and animal health as well as non-pharmaceutical areas.
Rheumatoid arthritis: biologic drugs at least as safe and efficient as methotrexate (28.5.2015)
Rheumatoid arthritis is treated with synthetic disease-modifying anti-rheumatic (sDMARDs) and biologic drugs. More than 20% of Finnish patients with rheumatoid arthritis are using biologic drugs based on the inhibition of tumor necrosis factor, with a majority of them in combination therapy with sDMARDs. Kalle Aaltonen found out in his doctoral thesis that the efficacy and safety of biologic drugs are comparable to methotrexate and only few differences between individual agents could be observed.
Rhazya stricta: biotechnological methods developed for alkaloid production (26.5.2015)
Amir Akhgari developed the first simple and efficient gene transfer method for Rhazya stricta, a traditional medicinal plant in the Middle East and South Asia. Rhazya stricta produces a large number of terpenoid indole alkaloids, and some of them have important pharmacological properties. He also established new analytical methods which made possible a comprehensive investigation of the alkaloids.
- News and events, University of Helsinki
- Helsinki University Bulletin
- Faculty of Pharmacy news archive
University of Helsinki
- University of Helsinki in brief
- Science and Research
- Services and cooperation
- Studying & How to apply?
- Social interaction
- International affairs & International Staff Services
Living in Finland
- Suomi.fi - information on public services
- Infobank - information in 15 languages
- Virtual Finland
- HERA Promotianal Video